报价延迟最少15分钟:2026/11/05 02:39 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
19.29 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.12/--
|
|
企业价值
5.33B
|
| 资产负债 |
|
每股账面净值
12.87
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
2.72B
|
|
每股收益
0.44
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables. |
